Qube Research & Technologies LTD Hille Vax, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Hille Vax, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 49,963 shares of HLVX stock, worth $104,422. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,963Holding current value
$104,422% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding HLVX
# of Institutions
65Shares Held
35.5MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$22.2 Million1.11% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$10.3 Million0.59% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.42MShares$5.06 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.37 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.95MShares$4.08 Million0.0% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.9M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.